Lite Strategy, Inc. (LITS)

Lite Strategy, Inc. (LITS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $36.2M; returns 1 day -2.5%, 1 week +0.9%, 1 year -38.0%.

Lite Strategy, Inc. (NASDAQ: LITS) is a company that underwent a significant strategic transformation in September 2025, changing its name from MEI Pharma, Inc. and pivoting from a clinical-stage pharmaceutical company to a "Litecoin Treasury Company".

Groups LITS belongs to

• Cryptocurrency Adjacent
• Strategic Pivot
• Blockchain Technology
• Financials Sector
• Biotechnology
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics

LITS financial model: income statement, cash flow and balance sheet